{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "06",
                "@timestamp": "2022-11-06T12:47:38.000038-05:00",
                "@year": "2022",
                "@month": "11"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "National Institute of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Cancer Institute",
                    "xocs:funding-agency-acronym": "NCI",
                    "xocs:funding-agency": "National Cancer Institute",
                    "xocs:funding-id": [
                        {"$": "P30CA091842"},
                        {"$": "P50CA196510"},
                        {"$": "R01CA240983"}
                    ],
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                },
                {
                    "xocs:funding-agency-matched-string": "Susan G. Komen for the Cure",
                    "xocs:funding-agency": "Susan G. Komen for the Cure",
                    "xocs:funding-id": "KG111025",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000869",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Foundation for Barnes-Jewish Hospital",
                    "xocs:funding-agency": "Foundation for Barnes-Jewish Hospital",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007338",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Alvin J. Siteman Cancer Center",
                    "xocs:funding-agency": "Alvin J. Siteman Cancer Center",
                    "xocs:funding-id": "4035",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014571",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {"xocs:funding-agency-matched-string": "king of Thailand"}
            ],
            "xocs:funding-addon-generated-timestamp": "2023-03-01T23:09:43.558943Z",
            "xocs:funding-text": "This project was supported by grants from Susan G. Komen for the Cure (KG111025), the Alvin J. Siteman Cancer Center (Siteman Investment Program grant 4035), The National Institute of Health (NIH) Research Project Grant R01 CA240983, the National Cancer Institute at the NIH (Cancer Center Support Grant P30-CA091842 and SPORE in Pancreatic Cancer P50-CA196510), the Foundation for Barnes-Jewish Hospital (to SPG), and Prince Mahidol Award Youth Program of Prince Mahidol Award Foundation under the Royal Patronage of HM the king of Thailand (to SS).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60022756",
                            "@country": "usa",
                            "city": "St Louis",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Washington University School of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60022756",
                                "@dptid": "111075201"
                            },
                            "state": "MO",
                            "@affiliation-instance-id": "2011025856-d5122bb810184c1e4072848b612565d9",
                            "ce:source-text": "Department of Surgery, Washington University School of Medicine, St Louis, MO, USA",
                            "@dptid": "111075201"
                        },
                        "author": [
                            {
                                "ce:given-name": "Suangson",
                                "preferred-name": {
                                    "ce:given-name": "Suangson",
                                    "ce:initials": "S.",
                                    "ce:surname": "Supabphol",
                                    "ce:indexed-name": "Supabphol S."
                                },
                                "@author-instance-id": "2011025856-23d27802517da32dc724686becafaa22",
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Supabphol",
                                "@auid": "57217653382",
                                "ce:indexed-name": "Supabphol S."
                            },
                            {
                                "ce:given-name": "Lijin",
                                "preferred-name": {
                                    "ce:given-name": "Lijin",
                                    "ce:initials": "L.",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li L."
                                },
                                "@author-instance-id": "2011025856-f9f58331a47a21d20cee5e5fc1af4034",
                                "@seq": "2",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Li",
                                "@auid": "7501453101",
                                "ce:indexed-name": "Li L."
                            },
                            {
                                "ce:given-name": "S. Peter",
                                "preferred-name": {
                                    "ce:given-name": "S. Peter",
                                    "ce:initials": "S.P.",
                                    "ce:surname": "Goedegebuure",
                                    "ce:indexed-name": "Goedegebuure S.P."
                                },
                                "@author-instance-id": "2011025856-c182faf608444c3e71eb9d12789ae2c8",
                                "@seq": "3",
                                "ce:initials": "S.P.",
                                "@date-locked": "2021-07-13T15:08:46.883",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Goedegebuure",
                                "@auid": "7003362460",
                                "ce:indexed-name": "Goedegebuure S.P."
                            },
                            {
                                "ce:given-name": "William E.",
                                "preferred-name": {
                                    "ce:given-name": "William E.",
                                    "ce:initials": "W.E.",
                                    "ce:surname": "Gillanders",
                                    "ce:indexed-name": "Gillanders W.E."
                                },
                                "@author-instance-id": "2011025856-6a5a111b1fcf533b07218228e7783815",
                                "@seq": "4",
                                "ce:initials": "W.E.",
                                "@date-locked": "2021-07-13T15:08:46.883",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Gillanders",
                                "@auid": "7003463023",
                                "ce:indexed-name": "Gillanders W.E."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "The Center of Excellence in Systems Biology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "115138551"
                            },
                            "@affiliation-instance-id": "2011025856-9cdc8e0389cd2b0e33d4fffae6501581",
                            "ce:source-text": "The Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "115138551"
                        },
                        "author": [{
                            "ce:given-name": "Suangson",
                            "preferred-name": {
                                "ce:given-name": "Suangson",
                                "ce:initials": "S.",
                                "ce:surname": "Supabphol",
                                "ce:indexed-name": "Supabphol S."
                            },
                            "@author-instance-id": "2011025856-23d27802517da32dc724686becafaa22",
                            "@seq": "1",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Supabphol",
                            "@auid": "57217653382",
                            "ce:indexed-name": "Supabphol S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60273994",
                            "@country": "usa",
                            "city": "St Louis",
                            "organization": {"$": "The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine"},
                            "affiliation-id": [
                                {"@afid": "60273994"},
                                {"@afid": "60022756"},
                                {"@afid": "60016667"}
                            ],
                            "state": "MO",
                            "@affiliation-instance-id": "2011025856-7021484a419a52385e42905c31eea624",
                            "ce:source-text": "The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St Louis, MO, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "S. Peter",
                                "preferred-name": {
                                    "ce:given-name": "S. Peter",
                                    "ce:initials": "S.P.",
                                    "ce:surname": "Goedegebuure",
                                    "ce:indexed-name": "Goedegebuure S.P."
                                },
                                "@author-instance-id": "2011025856-c182faf608444c3e71eb9d12789ae2c8",
                                "@seq": "3",
                                "ce:initials": "S.P.",
                                "@date-locked": "2021-07-13T15:08:46.883",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Goedegebuure",
                                "@auid": "7003362460",
                                "ce:indexed-name": "Goedegebuure S.P."
                            },
                            {
                                "ce:given-name": "William E.",
                                "preferred-name": {
                                    "ce:given-name": "William E.",
                                    "ce:initials": "W.E.",
                                    "ce:surname": "Gillanders",
                                    "ce:indexed-name": "Gillanders W.E."
                                },
                                "@author-instance-id": "2011025856-6a5a111b1fcf533b07218228e7783815",
                                "@seq": "4",
                                "ce:initials": "W.E.",
                                "@date-locked": "2021-07-13T15:08:46.883",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Gillanders",
                                "@auid": "7003463023",
                                "ce:indexed-name": "Gillanders W.E."
                            }
                        ]
                    }
                ],
                "citation-title": "Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy",
                "abstracts": "Â© 2021 Informa UK Limited, trading as Taylor & Francis Group.Introduction: Derived from genetic alterations, cancer neoantigens are proteins with novel amino acid sequences that can be recognized by the immune system. Recent evidence demonstrates that cancer neoantigens represent important targets of cancer immunotherapy. The goal of cancer neoantigen vaccines is to induce neoantigen-specific immune responses and antitumor immunity, while minimizing the potential for autoimmune toxicity. Advances in sequencing technologies, neoantigen prediction ?algorithms,? and other technologies have dramatically improved the ability to identify and prioritize cancer neoantigens. These advances have generated considerable enthusiasm for ?the ?development of neoantigen vaccines. Several neoantigen vaccine platforms are currently being evaluated in early phase clinical trials including the synthetic long peptide (SLP), RNA, dendritic cell (DC), and DNA vaccine platforms. Areas covered: In this review, we describe, evaluate the mechanism(s) of action, compare the advantages and disadvantages, and summarize early clinical experience with each vaccine platform. We provide perspectives on the future directions of the neoantigen vaccine field. All data are derived from PubMed and ClinicalTrials search updated in October 2020. Expert opinion: Although the initial clinical experience is promising, significant challenges to the success of neoantigen vaccines include limitations in neoantigen identification and the need to successfully target the immunosuppressive tumor microenvironment.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "@country": "usa",
                        "city": "St Louis",
                        "organization": [
                            {"$": "Department of Surgery"},
                            {"$": "Washington University School of Medicine"}
                        ],
                        "state": "MO",
                        "ce:source-text": "Department of Surgery, Washington University School of Medicine, St Louis, MO, USA"
                    },
                    "person": {
                        "ce:given-name": "William E.",
                        "ce:initials": "W.E.",
                        "ce:surname": "Gillanders",
                        "ce:indexed-name": "Gillanders W.E."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "cancer vaccine",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "clinical trial",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "delivery platforms",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Neoantigen",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.tandfonline.com/loi/ieid20",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Expert Opinion on Investigational Drugs",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "30",
                            "@issue": "5"
                        },
                        "pagerange": {
                            "@first": "529",
                            "@last": "541"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Expert Opinion on Investigational Drugs",
                    "publicationdate": {
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2021"
                        }
                    },
                    "codencode": "EOIDE",
                    "sourcetitle-abbrev": "Expert Opin. Invest. Drugs",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "17447658",
                            "@type": "electronic"
                        },
                        {
                            "$": "13543784",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Taylor and Francis Ltd."},
                    "@srcid": "21351"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "39",
                                    "classification-description": "Pharmacy"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": "59789-29-6",
                                "chemical-name": "carboxymethylcellulose polycytidylic polyinosinic acid polylysine"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antigens, Neoplasm"},
                                {"chemical-name": "Cancer Vaccines"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This project was supported by grants from Susan G. Komen for the Cure (KG111025), the Alvin J. Siteman Cancer Center (Siteman Investment Program grant 4035), The National Institute of Health (NIH) Research Project Grant R01 CA240983, the National Cancer Institute at the NIH (Cancer Center Support Grant P30-CA091842 and SPORE in Pancreatic Cancer P50-CA196510), the Foundation for Barnes-Jewish Hospital (to SPG), and Prince Mahidol Award Youth Program of Prince Mahidol Award Foundation under the Royal Patronage of HM the king of Thailand (to SS).",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "08",
                    "@timestamp": "BST 03:27:12",
                    "@year": "2021",
                    "@month": "11"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2011025856",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "634438661",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "932342158",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210337779",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "33641576",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2021117912",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20211497629",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2021235279",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20211151970",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021093425983X",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85103547768",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85103547768",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "634438661",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76876599",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1080/13543784.2021.1896702"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "88",
                "reference": [
                    {
                        "ref-fulltext": "Jiang T, Shi T, Zhang H, et al. Tumor neoantigens: from basic research to clinical applications. J Hematol Oncol. 2019 Sep 6; 12 (1): 93.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Tumor neoantigens: from basic research to clinical applications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071991234",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "93"}
                            },
                            "ref-text": "Sep, 6",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Jiang",
                                        "ce:indexed-name": "Jiang T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shi",
                                        "ce:indexed-name": "Shi T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hematol Oncol"
                        },
                        "ce:source-text": "Jiang T, Shi T, Zhang H, et al. Tumor neoantigens: from basic research to clinical applications. J Hematol Oncol. 2019 Sep 6; 12 (1): 93."
                    },
                    {
                        "ref-fulltext": "Efremova M, Finotello F, Rieder D, et al. Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy. Front Immunol. 2017; 8: 1679.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85035323651",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "1679"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Efremova",
                                        "ce:indexed-name": "Efremova M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Finotello",
                                        "ce:indexed-name": "Finotello F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Rieder",
                                        "ce:indexed-name": "Rieder D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Efremova M, Finotello F, Rieder D, et al. Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy. Front Immunol. 2017; 8: 1679."
                    },
                    {
                        "ref-fulltext": "Angelova M, Mlecnik B, Vasaturo A, et al. Evolution of Metastases in Space and Time under Immune Selection. Cell. 2018 Oct 18; 175 (3): 751\u2013765 e16.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Evolution of Metastases in Space and Time under Immune Selection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055072341",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "175",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "751",
                                    "@last": "765 e16"
                                }
                            },
                            "ref-text": "Oct, 18",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Angelova",
                                        "ce:indexed-name": "Angelova M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Mlecnik",
                                        "ce:indexed-name": "Mlecnik B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Vasaturo",
                                        "ce:indexed-name": "Vasaturo A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Angelova M, Mlecnik B, Vasaturo A, et al. Evolution of Metastases in Space and Time under Immune Selection. Cell. 2018 Oct 18; 175 (3): 751\u2013765 e16."
                    },
                    {
                        "ref-fulltext": "O\u2019Donnell JS, Teng MWL, Smyth MJ., Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019 Mar; 16 (3): 151\u2013167.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cancer immunoediting and resistance to T cell-based immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058065042",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "151",
                                    "@last": "167"
                                }
                            },
                            "ref-text": "Mar",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.S.",
                                    "@_fa": "true",
                                    "ce:surname": "O\u2019Donnell",
                                    "ce:indexed-name": "O'Donnell J.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.W.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Teng",
                                    "ce:indexed-name": "Teng M.W.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Smyth",
                                    "ce:indexed-name": "Smyth M.J."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "O\u2019Donnell JS, Teng MWL, Smyth MJ., Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019 Mar; 16 (3): 151\u2013167."
                    },
                    {
                        "ref-fulltext": "Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015 Apr 3; 348 (6230): 74\u201380.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "T cell exclusion, immune privilege, and the tumor microenvironment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928771999",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "348",
                                    "@issue": "6230"
                                },
                                "pagerange": {
                                    "@first": "74",
                                    "@last": "80"
                                }
                            },
                            "ref-text": "Apr, 3",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Joyce",
                                    "ce:indexed-name": "Joyce J.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Fearon",
                                    "ce:indexed-name": "Fearon D.T."
                                }
                            ]},
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015 Apr 3; 348 (6230): 74\u201380."
                    },
                    {
                        "ref-fulltext": "Coulie PG, Van Den Eynde BJ, Van Der Bruggen P, et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer. 2014 Feb; 14 (2): 135\u2013146.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84894559188",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "135",
                                    "@last": "146"
                                }
                            },
                            "ref-text": "Feb",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Coulie",
                                        "ce:indexed-name": "Coulie P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Den Eynde",
                                        "ce:indexed-name": "Van Den Eynde B.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Der Bruggen",
                                        "ce:indexed-name": "Van Der Bruggen P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Cancer"
                        },
                        "ce:source-text": "Coulie PG, Van Den Eynde BJ, Van Der Bruggen P, et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer. 2014 Feb; 14 (2): 135\u2013146."
                    },
                    {
                        "ref-fulltext": "Farhood B, Najafi M, Mortezaee K. ?CD8? ?+? cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019 June; 234 (6): 8509\u20138521.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "?CD8? ?+? cytotoxic T lymphocytes in cancer immunotherapy: a review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058863495",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "234",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "8509",
                                    "@last": "8521"
                                }
                            },
                            "ref-text": "June",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Farhood",
                                    "ce:indexed-name": "Farhood B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Najafi",
                                    "ce:indexed-name": "Najafi M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Mortezaee",
                                    "ce:indexed-name": "Mortezaee K."
                                }
                            ]},
                            "ref-sourcetitle": "J Cell Physiol"
                        },
                        "ce:source-text": "Farhood B, Najafi M, Mortezaee K. ?CD8? ?+? cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019 June; 234 (6): 8509\u20138521."
                    },
                    {
                        "ref-fulltext": "Feldman SA, Assadipour Y, Kriley I, et al. Adoptive Cell ?Therapy\u2014Tumor-Infiltrating? Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors. Semin Oncol. 2015 Aug; 42 (4): 626\u2013639.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Adoptive Cell ?Therapy\u2014Tumor-Infiltrating? Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84940379637",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "626",
                                    "@last": "639"
                                }
                            },
                            "ref-text": "Aug",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Feldman",
                                        "ce:indexed-name": "Feldman S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Assadipour",
                                        "ce:indexed-name": "Assadipour Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Kriley",
                                        "ce:indexed-name": "Kriley I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Semin Oncol"
                        },
                        "ce:source-text": "Feldman SA, Assadipour Y, Kriley I, et al. Adoptive Cell ?Therapy\u2014Tumor-Infiltrating? Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors. Semin Oncol. 2015 Aug; 42 (4): 626\u2013639."
                    },
                    {
                        "ref-fulltext": "Pasetto A, Gros A, Robbins PF, et al. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunol Res. 2016 Sep 2; 4 (9): 734\u2013743.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85016143090",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "734",
                                    "@last": "743"
                                }
                            },
                            "ref-text": "Sep, 2",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Pasetto",
                                        "ce:indexed-name": "Pasetto A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gros",
                                        "ce:indexed-name": "Gros A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Robbins",
                                        "ce:indexed-name": "Robbins P.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Pasetto A, Gros A, Robbins PF, et al. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunol Res. 2016 Sep 2; 4 (9): 734\u2013743."
                    },
                    {
                        "ref-fulltext": "Yamamoto TN, Kishton RJ, Restifo NP. Developing neoantigen-targeted T ?cell\u2013based? treatments for solid tumors. Nat Med. 2019 Oct; 25 (10): 1488\u20131499.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Developing neoantigen-targeted T ?cell\u2013based? treatments for solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074205341",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1488",
                                    "@last": "1499"
                                }
                            },
                            "ref-text": "Oct",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Yamamoto",
                                    "ce:indexed-name": "Yamamoto T.N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Kishton",
                                    "ce:indexed-name": "Kishton R.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Restifo",
                                    "ce:indexed-name": "Restifo N.P."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Yamamoto TN, Kishton RJ, Restifo NP. Developing neoantigen-targeted T ?cell\u2013based? treatments for solid tumors. Nat Med. 2019 Oct; 25 (10): 1488\u20131499."
                    },
                    {
                        "ref-fulltext": "Riaz N, Havel JJ, Makarov V, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017 Nov 2; 171 (4): 934\u2013949 e16.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85031295254",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "171",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "934",
                                    "@last": "949 e16"
                                }
                            },
                            "ref-text": "Nov, 2",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Riaz",
                                        "ce:indexed-name": "Riaz N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Havel",
                                        "ce:indexed-name": "Havel J.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Makarov",
                                        "ce:indexed-name": "Makarov V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Riaz N, Havel JJ, Makarov V, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017 Nov 2; 171 (4): 934\u2013949 e16."
                    },
                    {
                        "ref-fulltext": "Bogen B, Fauskanger M, Haabeth OA, et al. ?CD4+? T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models. Cancer Immunol Immunother. 2019 Nov; 68 (11): 1865\u20131873.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "?CD4+? T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071576487",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1865",
                                    "@last": "1873"
                                }
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Bogen",
                                        "ce:indexed-name": "Bogen B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fauskanger",
                                        "ce:indexed-name": "Fauskanger M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Haabeth",
                                        "ce:indexed-name": "Haabeth O.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Immunother"
                        },
                        "ce:source-text": "Bogen B, Fauskanger M, Haabeth OA, et al. ?CD4+? T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models. Cancer Immunol Immunother. 2019 Nov; 68 (11): 1865\u20131873."
                    },
                    {
                        "ref-fulltext": "Kreiter S, Vormehr M, Van De Roemer N, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015 Apr 30; 520 (7549): 692\u2013696.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Mutant MHC class II epitopes drive therapeutic immune responses to cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928811341",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "520",
                                    "@issue": "7549"
                                },
                                "pagerange": {
                                    "@first": "692",
                                    "@last": "696"
                                }
                            },
                            "ref-text": "Apr, 30",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kreiter",
                                        "ce:indexed-name": "Kreiter S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Vormehr",
                                        "ce:indexed-name": "Vormehr M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Van De Roemer",
                                        "ce:indexed-name": "Van De Roemer N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Kreiter S, Vormehr M, Van De Roemer N, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015 Apr 30; 520 (7549): 692\u2013696."
                    },
                    {
                        "ref-fulltext": "Ostroumov D, Fekete-Drimusz N, Saborowski M, et al. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol Life Sci. 2018 Feb; 75 (4): 689\u2013713.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CD4 and CD8 T lymphocyte interplay in controlling tumor growth"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85031422016",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "75",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "689",
                                    "@last": "713"
                                }
                            },
                            "ref-text": "Feb",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Ostroumov",
                                        "ce:indexed-name": "Ostroumov D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Fekete-Drimusz",
                                        "ce:indexed-name": "Fekete-Drimusz N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Saborowski",
                                        "ce:indexed-name": "Saborowski M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Mol Life Sci"
                        },
                        "ce:source-text": "Ostroumov D, Fekete-Drimusz N, Saborowski M, et al. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol Life Sci. 2018 Feb; 75 (4): 689\u2013713."
                    },
                    {
                        "ref-fulltext": "Tay RE, Richardson EK, Toh HC. Revisiting the role of ?CD4+? T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. ? 2021 ? May; ?28? (?1\u20132?): 27.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Revisiting the role of ?CD4+? T cells in cancer immunotherapy-new insights into old paradigms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085372186",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {"@first": "27"}
                            },
                            "ref-text": "May",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Tay",
                                    "ce:indexed-name": "Tay R.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Richardson",
                                    "ce:indexed-name": "Richardson E.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Toh",
                                    "ce:indexed-name": "Toh H.C."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Gene Ther"
                        },
                        "ce:source-text": "Tay RE, Richardson EK, Toh HC. Revisiting the role of ?CD4+? T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. ? 2021 ? May; ?28? (?1\u20132?): 27."
                    },
                    {
                        "ref-fulltext": "Veatch JR, Jesernig BL, Kargl J, et al. Endogenous ?CD4? ?+? T Cells Recognize Neoantigens in Lung Cancer Patients,Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations. Cancer Immunol Res. 2019 Jun; 7 (6): 910\u2013922.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Endogenous ?CD4? ?+? T Cells Recognize Neoantigens in Lung Cancer Patients,Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067216453",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "910",
                                    "@last": "922"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Veatch",
                                        "ce:indexed-name": "Veatch J.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Jesernig",
                                        "ce:indexed-name": "Jesernig B.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kargl",
                                        "ce:indexed-name": "Kargl J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Veatch JR, Jesernig BL, Kargl J, et al. Endogenous ?CD4? ?+? T Cells Recognize Neoantigens in Lung Cancer Patients,Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations. Cancer Immunol Res. 2019 Jun; 7 (6): 910\u2013922."
                    },
                    {
                        "ref-fulltext": "Linnemann C, Van Buuren MM, Bies L, et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat Med. 2015 Jan; 21 (1): 81\u201385.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84961323160",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "81",
                                    "@last": "85"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Linnemann",
                                        "ce:indexed-name": "Linnemann C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Buuren",
                                        "ce:indexed-name": "Van Buuren M.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Bies",
                                        "ce:indexed-name": "Bies L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Linnemann C, Van Buuren MM, Bies L, et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat Med. 2015 Jan; 21 (1): 81\u201385."
                    },
                    {
                        "ref-fulltext": "Ferris ST, Durai V, Wu R, et al. cDC1 prime and are licensed by ?CD4+? T cells to induce anti-tumour immunity. Nature. 2020 Aug; 584 (7822): 624\u2013629.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "cDC1 prime and are licensed by ?CD4+? T cells to induce anti-tumour immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089311605",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "584",
                                    "@issue": "7822"
                                },
                                "pagerange": {
                                    "@first": "624",
                                    "@last": "629"
                                }
                            },
                            "ref-text": "Aug",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferris",
                                        "ce:indexed-name": "Ferris S.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Durai",
                                        "ce:indexed-name": "Durai V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Ferris ST, Durai V, Wu R, et al. cDC1 prime and are licensed by ?CD4+? T cells to induce anti-tumour immunity. Nature. 2020 Aug; 584 (7822): 624\u2013629."
                    },
                    {
                        "ref-fulltext": "Alspach E, Lussier DM, Miceli AP, et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 2019 Oct;; 574 (7780): 696\u2013701.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "MHC-II neoantigens shape tumour immunity and response to immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074223743",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "574",
                                    "@issue": "7780"
                                },
                                "pagerange": {
                                    "@first": "696",
                                    "@last": "701"
                                }
                            },
                            "ref-text": "Oct",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Alspach",
                                        "ce:indexed-name": "Alspach E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Lussier",
                                        "ce:indexed-name": "Lussier D.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Miceli",
                                        "ce:indexed-name": "Miceli A.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Alspach E, Lussier DM, Miceli AP, et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 2019 Oct;; 574 (7780): 696\u2013701."
                    },
                    {
                        "ref-fulltext": "Busselaar J, Tian S, Van Eenennaam H, et al. Helpless Priming Sends ?CD8+? T Cells on the Road to Exhaustion. Front Immunol. 2020; 11: 592569.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Helpless Priming Sends ?CD8+? T Cells on the Road to Exhaustion"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85094127423",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "592569"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Busselaar",
                                        "ce:indexed-name": "Busselaar J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Tian",
                                        "ce:indexed-name": "Tian S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Eenennaam",
                                        "ce:indexed-name": "Van Eenennaam H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Busselaar J, Tian S, Van Eenennaam H, et al. Helpless Priming Sends ?CD8+? T Cells on the Road to Exhaustion. Front Immunol. 2020; 11: 592569."
                    },
                    {
                        "ref-fulltext": "Quezada SA, Simpson TR, Peggs KS, et al. Tumor-reactive ?CD4+? T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010 Mar 15; 207 (3): 637\u2013650.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Tumor-reactive ?CD4+? T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77949522803",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "207",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "637",
                                    "@last": "650"
                                }
                            },
                            "ref-text": "Mar, 15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Quezada",
                                        "ce:indexed-name": "Quezada S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Simpson",
                                        "ce:indexed-name": "Simpson T.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Peggs",
                                        "ce:indexed-name": "Peggs K.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Exp Med"
                        },
                        "ce:source-text": "Quezada SA, Simpson TR, Peggs KS, et al. Tumor-reactive ?CD4+? T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010 Mar 15; 207 (3): 637\u2013650."
                    },
                    {
                        "ref-fulltext": "Hodge K, Supabphol S, Kumar P, et al. Recent developments in neoantigen-based cancer vaccines. Asian Pac J Allergy Immunol. 2020 Jun;; 38 (2): 91\u2013101.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Recent developments in neoantigen-based cancer vaccines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087466943",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "91",
                                    "@last": "101"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hodge",
                                        "ce:indexed-name": "Hodge K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Supabphol",
                                        "ce:indexed-name": "Supabphol S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kumar",
                                        "ce:indexed-name": "Kumar P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Asian Pac J Allergy Immunol"
                        },
                        "ce:source-text": "Hodge K, Supabphol S, Kumar P, et al. Recent developments in neoantigen-based cancer vaccines. Asian Pac J Allergy Immunol. 2020 Jun;; 38 (2): 91\u2013101."
                    },
                    {
                        "ref-fulltext": "Peng M, Mo Y, Wang Y, et al. Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019 Aug 23; 18 (1): 128.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Neoantigen vaccine: an emerging tumor immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071429889",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "128"}
                            },
                            "ref-text": "Aug, 23",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Peng",
                                        "ce:indexed-name": "Peng M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Mo",
                                        "ce:indexed-name": "Mo Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer"
                        },
                        "ce:source-text": "Peng M, Mo Y, Wang Y, et al. Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019 Aug 23; 18 (1): 128."
                    },
                    {
                        "ref-fulltext": "Castle JC, Kreiter S, Diekmann J, et al. Exploiting the mutanome for tumor vaccination. Cancer Res. 2012 Mar 1; 72 (5): 1081\u20131091.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Exploiting the mutanome for tumor vaccination"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84857725402",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1081",
                                    "@last": "1091"
                                }
                            },
                            "ref-text": "Mar, 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Castle",
                                        "ce:indexed-name": "Castle J.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kreiter",
                                        "ce:indexed-name": "Kreiter S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Diekmann",
                                        "ce:indexed-name": "Diekmann J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Castle JC, Kreiter S, Diekmann J, et al. Exploiting the mutanome for tumor vaccination. Cancer Res. 2012 Mar 1; 72 (5): 1081\u20131091."
                    },
                    {
                        "ref-fulltext": "Li L, Goedegebuure SP, Gillanders WE. Preclinical and clinical development of neoantigen vaccines. Ann Oncol. 2017 Dec 1; 28 (12): xii11\u2013xii17.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Preclinical and clinical development of neoantigen vaccines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85039558153",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "xii11",
                                    "@last": "xii17"
                                }
                            },
                            "ref-text": "Dec, 1",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Goedegebuure",
                                    "ce:indexed-name": "Goedegebuure S.P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Gillanders",
                                    "ce:indexed-name": "Gillanders W.E."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Li L, Goedegebuure SP, Gillanders WE. Preclinical and clinical development of neoantigen vaccines. Ann Oncol. 2017 Dec 1; 28 (12): xii11\u2013xii17."
                    },
                    {
                        "ref-fulltext": "Yadav M, Jhunjhunwala S, Phung QT, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 2014 Nov 27; 515 (7528): 572\u2013576.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920956731",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "515",
                                    "@issue": "7528"
                                },
                                "pagerange": {
                                    "@first": "572",
                                    "@last": "576"
                                }
                            },
                            "ref-text": "Nov, 27",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Yadav",
                                        "ce:indexed-name": "Yadav M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Jhunjhunwala",
                                        "ce:indexed-name": "Jhunjhunwala S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Phung",
                                        "ce:indexed-name": "Phung Q.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Yadav M, Jhunjhunwala S, Phung QT, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 2014 Nov 27; 515 (7528): 572\u2013576."
                    },
                    {
                        "ref-fulltext": "Kranz LM, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016 Jun 16; 534 (7607): 396\u2013401.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975832642",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "534",
                                    "@issue": "7607"
                                },
                                "pagerange": {
                                    "@first": "396",
                                    "@last": "401"
                                }
                            },
                            "ref-text": "Jun, 16",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kranz",
                                        "ce:indexed-name": "Kranz L.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Diken",
                                        "ce:indexed-name": "Diken M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Haas",
                                        "ce:indexed-name": "Haas H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Kranz LM, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016 Jun 16; 534 (7607): 396\u2013401."
                    },
                    {
                        "ref-fulltext": "Fennemann FL, De Vries ?IJM?, Figdor CG, et al. Attacking Tumors From All Sides: personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity. Front Immunol. 2019; 10: 824.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Attacking Tumors From All Sides: personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065497414",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "824"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Fennemann",
                                        "ce:indexed-name": "Fennemann F.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "De Vries",
                                        "ce:indexed-name": "De Vries I.J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Figdor",
                                        "ce:indexed-name": "Figdor C.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Fennemann FL, De Vries ?IJM?, Figdor CG, et al. Attacking Tumors From All Sides: personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity. Front Immunol. 2019; 10: 824."
                    },
                    {
                        "ref-fulltext": "Roudko V, Greenbaum B, Bhardwaj N. Computational Prediction and Validation of Tumor-Associated Neoantigens. Front Immunol. 2020; 11: 27.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Computational Prediction and Validation of Tumor-Associated Neoantigens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079133464",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "27"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Roudko",
                                    "ce:indexed-name": "Roudko V."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Greenbaum",
                                    "ce:indexed-name": "Greenbaum B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhardwaj",
                                    "ce:indexed-name": "Bhardwaj N."
                                }
                            ]},
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Roudko V, Greenbaum B, Bhardwaj N. Computational Prediction and Validation of Tumor-Associated Neoantigens. Front Immunol. 2020; 11: 27."
                    },
                    {
                        "ref-fulltext": "Zhang X, Qi Y, Zhang Q, et al. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy. ?Biomedicine & Pharmacotherapy?. 2019 Dec; 120: 109542.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073237338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "120"},
                                "pagerange": {"@first": "109542"}
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Qi",
                                        "ce:indexed-name": "Qi Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "?Biomedicine & Pharmacotherapy?"
                        },
                        "ce:source-text": "Zhang X, Qi Y, Zhang Q, et al. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy. ?Biomedicine & Pharmacotherapy?. 2019 Dec; 120: 109542."
                    },
                    {
                        "ref-fulltext": "Abelin JG, Keskin DB, Sarkizova S, et al. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity. 2017 Feb 21; 46 (2): 315\u2013326.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85013878753",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "46",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "315",
                                    "@last": "326"
                                }
                            },
                            "ref-text": "Feb, 21",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Abelin",
                                        "ce:indexed-name": "Abelin J.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Keskin",
                                        "ce:indexed-name": "Keskin D.B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sarkizova",
                                        "ce:indexed-name": "Sarkizova S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Immunity"
                        },
                        "ce:source-text": "Abelin JG, Keskin DB, Sarkizova S, et al. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity. 2017 Feb 21; 46 (2): 315\u2013326."
                    },
                    {
                        "ref-fulltext": "Bassani-Sternberg M, Braunlein E, Klar R, et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat Commun. 2016 Nov; 7 (?1?): 13404.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84995916390",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "13404"}
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bassani-Sternberg",
                                        "ce:indexed-name": "Bassani-Sternberg M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Braunlein",
                                        "ce:indexed-name": "Braunlein E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Klar",
                                        "ce:indexed-name": "Klar R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Commun"
                        },
                        "ce:source-text": "Bassani-Sternberg M, Braunlein E, Klar R, et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat Commun. 2016 Nov; 7 (?1?): 13404."
                    },
                    {
                        "ref-fulltext": "Purcell AW, Ramarathinam SH, Ternette N. Mass ?spectrometry\u2013based? identification of MHC-bound peptides for immunopeptidomics. Nat Protoc. 2019 Jun; 14 (6): 1687\u20131707.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Mass ?spectrometry\u2013based? identification of MHC-bound peptides for immunopeptidomics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065996365",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1687",
                                    "@last": "1707"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Purcell",
                                    "ce:indexed-name": "Purcell A.W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramarathinam",
                                    "ce:indexed-name": "Ramarathinam S.H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Ternette",
                                    "ce:indexed-name": "Ternette N."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Protoc"
                        },
                        "ce:source-text": "Purcell AW, Ramarathinam SH, Ternette N. Mass ?spectrometry\u2013based? identification of MHC-bound peptides for immunopeptidomics. Nat Protoc. 2019 Jun; 14 (6): 1687\u20131707."
                    },
                    {
                        "ref-fulltext": "Wells DK, Van Buuren MM, Dang KK, et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell. 2020 Oct 29; 183 (3): 818\u2013834 e13.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85094120480",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "183",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "818",
                                    "@last": "834 e13"
                                }
                            },
                            "ref-text": "Oct, 29",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Wells",
                                        "ce:indexed-name": "Wells D.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Buuren",
                                        "ce:indexed-name": "Van Buuren M.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Dang",
                                        "ce:indexed-name": "Dang K.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Wells DK, Van Buuren MM, Dang KK, et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell. 2020 Oct 29; 183 (3): 818\u2013834 e13."
                    },
                    {
                        "ref-fulltext": "Hundal J, Kiwala S, McMichael J, et al. pVACtools: a Computational Toolkit to Identify and Visualize Cancer Neoantigens. Cancer Immunol Res. 2020 Mar; 8 (3): 409\u2013420.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "pVACtools: a Computational Toolkit to Identify and Visualize Cancer Neoantigens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079886645",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "409",
                                    "@last": "420"
                                }
                            },
                            "ref-text": "Mar",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hundal",
                                        "ce:indexed-name": "Hundal J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kiwala",
                                        "ce:indexed-name": "Kiwala S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "McMichael",
                                        "ce:indexed-name": "McMichael J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Hundal J, Kiwala S, McMichael J, et al. pVACtools: a Computational Toolkit to Identify and Visualize Cancer Neoantigens. Cancer Immunol Res. 2020 Mar; 8 (3): 409\u2013420."
                    },
                    {
                        "ref-fulltext": "Hundal J, Carreno BM, Petti AA, et al. pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 2016 Jan 29; 8 (1): 11.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84957108846",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "11"}
                            },
                            "ref-text": "Jan, 29",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hundal",
                                        "ce:indexed-name": "Hundal J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Carreno",
                                        "ce:indexed-name": "Carreno B.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Petti",
                                        "ce:indexed-name": "Petti A.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Genome Med"
                        },
                        "ce:source-text": "Hundal J, Carreno BM, Petti AA, et al. pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 2016 Jan 29; 8 (1): 11."
                    },
                    {
                        "ref-fulltext": "Hundal J, Kiwala S, Feng ?-Y-Y?, et al. Accounting for proximal variants improves neoantigen prediction. Nat Genet. 2019 Jan; 51 (1): 175\u2013179.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Accounting for proximal variants improves neoantigen prediction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058058699",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "51",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "175",
                                    "@last": "179"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hundal",
                                        "ce:indexed-name": "Hundal J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kiwala",
                                        "ce:indexed-name": "Kiwala S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.-Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng Y.-Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Genet"
                        },
                        "ce:source-text": "Hundal J, Kiwala S, Feng ?-Y-Y?, et al. Accounting for proximal variants improves neoantigen prediction. Nat Genet. 2019 Jan; 51 (1): 175\u2013179."
                    },
                    {
                        "ref-fulltext": "Fleri W, Selecting thresholds (cut-offs) for MHC class I and II binding predictions [Web Page]. Immune Epitope Database and Analysis Resource. [cited 2000 Nov 17]. Available from: https://help.iedb.org/hc/en-us/articles/114094151811-Selecting-thresholds-cut-offs-for-MHC-class-I-and-II-binding-predictions",
                        "@id": "38",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://help.iedb.org/hc/en-us/articles/114094151811-Selecting-thresholds-cut-offs-for-MHC-class-I-and-II-binding-predictions",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84927730557",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available from,. [cited 2000 Nov 17]",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Fleri",
                                    "ce:indexed-name": "Fleri W."
                                }],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "Selecting thresholds (cut-offs) for MHC class I and II binding predictions [Web Page].",
                                    "ce:indexed-name": "Selecting thresholds (cut-offs) for MHC class I and II binding predictions [Web Page]."
                                }
                            },
                            "ref-sourcetitle": "Immune Epitope Database and Analysis Resource"
                        },
                        "ce:source-text": "Fleri W, Selecting thresholds (cut-offs) for MHC class I and II binding predictions [Web Page]. Immune Epitope Database and Analysis Resource. [cited 2000 Nov 17]. Available from: https://help.iedb.org/hc/en-us/articles/114094151811-Selecting-thresholds-cut-offs-for-MHC-class-I-and-II-binding-predictions"
                    },
                    {
                        "ref-fulltext": "Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013; 31 (?1?): 443\u2013473.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Pathways of antigen processing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84875510924",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "443",
                                    "@last": "473"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Blum",
                                    "ce:indexed-name": "Blum J.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Wearsch",
                                    "ce:indexed-name": "Wearsch P.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Cresswell",
                                    "ce:indexed-name": "Cresswell P."
                                }
                            ]},
                            "ref-sourcetitle": "Annu Rev Immunol"
                        },
                        "ce:source-text": "Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013; 31 (?1?): 443\u2013473."
                    },
                    {
                        "ref-fulltext": "Cruz FM, Colbert JD, Merino E, et al. The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules. Annu Rev Immunol. 2017 Apr; 35 (?1?): 149\u2013176.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018266736",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "149",
                                    "@last": "176"
                                }
                            },
                            "ref-text": "Apr",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cruz",
                                        "ce:indexed-name": "Cruz F.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Colbert",
                                        "ce:indexed-name": "Colbert J.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Merino",
                                        "ce:indexed-name": "Merino E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Annu Rev Immunol"
                        },
                        "ce:source-text": "Cruz FM, Colbert JD, Merino E, et al. The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules. Annu Rev Immunol. 2017 Apr; 35 (?1?): 149\u2013176."
                    },
                    {
                        "ref-fulltext": "Azmi F, Ahmad Fuaad ?AAH?, Skwarczynski M, et al. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother. 2014; 10 (3): 778\u2013796.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Recent progress in adjuvant discovery for peptide-based subunit vaccines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84898481288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "778",
                                    "@last": "796"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Azmi",
                                        "ce:indexed-name": "Azmi F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.A.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahmad Fuaad",
                                        "ce:indexed-name": "Ahmad Fuaad A.A.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Skwarczynski",
                                        "ce:indexed-name": "Skwarczynski M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hum Vaccin Immunother"
                        },
                        "ce:source-text": "Azmi F, Ahmad Fuaad ?AAH?, Skwarczynski M, et al. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother. 2014; 10 (3): 778\u2013796."
                    },
                    {
                        "ref-fulltext": "Saxena M, Sabado RL, La Mar M, et al. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: a Randomized Double-Blinded Placebo Controlled Trial. Front Immunol. 2019; 10: 725.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: a Randomized Double-Blinded Placebo Controlled Trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065426077",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "725"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Saxena",
                                        "ce:indexed-name": "Saxena M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Sabado",
                                        "ce:indexed-name": "Sabado R.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "La Mar",
                                        "ce:indexed-name": "La Mar M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Saxena M, Sabado RL, La Mar M, et al. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: a Randomized Double-Blinded Placebo Controlled Trial. Front Immunol. 2019; 10: 725."
                    },
                    {
                        "ref-fulltext": "Kinkead HL, Hopkins A, Lutz E, et al. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight. 2018 Oct 18; 3 (?20?): 20.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062378170",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "20"
                                },
                                "pagerange": {"@first": "20"}
                            },
                            "ref-text": "Oct, 18",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Kinkead",
                                        "ce:indexed-name": "Kinkead H.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hopkins",
                                        "ce:indexed-name": "Hopkins A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Lutz",
                                        "ce:indexed-name": "Lutz E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JCI Insight"
                        },
                        "ce:source-text": "Kinkead HL, Hopkins A, Lutz E, et al. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight. 2018 Oct 18; 3 (?20?): 20."
                    },
                    {
                        "ref-fulltext": "Schneble E, Clifton GT, Hale DF, et al. Peptide-Based Cancer Vaccine Strategies and Clinical Results. Methods Mol Biol. 2016; 1403: 797\u2013817.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Peptide-Based Cancer Vaccine Strategies and Clinical Results"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84963865387",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1403"},
                                "pagerange": {
                                    "@first": "797",
                                    "@last": "817"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Schneble",
                                        "ce:indexed-name": "Schneble E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Clifton",
                                        "ce:indexed-name": "Clifton G.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Hale",
                                        "ce:indexed-name": "Hale D.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Methods Mol Biol"
                        },
                        "ce:source-text": "Schneble E, Clifton GT, Hale DF, et al. Peptide-Based Cancer Vaccine Strategies and Clinical Results. Methods Mol Biol. 2016; 1403: 797\u2013817."
                    },
                    {
                        "ref-fulltext": "Fang Y, Mo F, Shou J, et al. A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors. Clin Cancer Res. 2020 Sep 1; 26 (17): 4511\u20134520.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098672982",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "4511",
                                    "@last": "4520"
                                }
                            },
                            "ref-text": "Sep, 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Fang",
                                        "ce:indexed-name": "Fang Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Mo",
                                        "ce:indexed-name": "Mo F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Shou",
                                        "ce:indexed-name": "Shou J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Fang Y, Mo F, Shou J, et al. A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors. Clin Cancer Res. 2020 Sep 1; 26 (17): 4511\u20134520."
                    },
                    {
                        "ref-fulltext": "Hilf N, Kuttruff-Coqui S, Frenzel K, et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature. 2019 Jan; 565 (7738): 240\u2013245.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Actively personalized vaccination trial for newly diagnosed glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0046",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059762738",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "565",
                                    "@issue": "7738"
                                },
                                "pagerange": {
                                    "@first": "240",
                                    "@last": "245"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Hilf",
                                        "ce:indexed-name": "Hilf N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kuttruff-Coqui",
                                        "ce:indexed-name": "Kuttruff-Coqui S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Frenzel",
                                        "ce:indexed-name": "Frenzel K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Hilf N, Kuttruff-Coqui S, Frenzel K, et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature. 2019 Jan; 565 (7738): 240\u2013245."
                    },
                    {
                        "ref-fulltext": "Keskin DB, Anandappa AJ, Sun J, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019 Jan; 565 (7738): 234\u2013239.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0047",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059785792",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "565",
                                    "@issue": "7738"
                                },
                                "pagerange": {
                                    "@first": "234",
                                    "@last": "239"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Keskin",
                                        "ce:indexed-name": "Keskin D.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Anandappa",
                                        "ce:indexed-name": "Anandappa A.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Keskin DB, Anandappa AJ, Sun J, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019 Jan; 565 (7738): 234\u2013239."
                    },
                    {
                        "ref-fulltext": "Ott PA, Hu Z, Keskin DB, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017 Jul 13; 547 (7662): 217\u2013221.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "An immunogenic personal neoantigen vaccine for patients with melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0048",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85024377220",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "547",
                                    "@issue": "7662"
                                },
                                "pagerange": {
                                    "@first": "217",
                                    "@last": "221"
                                }
                            },
                            "ref-text": "Jul, 13",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ott",
                                        "ce:indexed-name": "Ott P.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Keskin",
                                        "ce:indexed-name": "Keskin D.B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Ott PA, Hu Z, Keskin DB, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017 Jul 13; 547 (7662): 217\u2013221."
                    },
                    {
                        "ref-fulltext": "Ott PA, Hu-Lieskovan S, Chmielowski B, et al. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. Cell. 2020 Oct 15; 183 (2): 347\u2013362 e24.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0049",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092455165",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "183",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "347",
                                    "@last": "362 e24"
                                }
                            },
                            "ref-text": "Oct, 15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ott",
                                        "ce:indexed-name": "Ott P.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu-Lieskovan",
                                        "ce:indexed-name": "Hu-Lieskovan S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Chmielowski",
                                        "ce:indexed-name": "Chmielowski B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Ott PA, Hu-Lieskovan S, Chmielowski B, et al. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. Cell. 2020 Oct 15; 183 (2): 347\u2013362 e24."
                    },
                    {
                        "ref-fulltext": "Wages NA, Slingluff CL, Jr., Bullock TN, et al. Tailoring early-phase clinical trial design to address multiple research objectives. Cancer Immunol Immunother. 2020 Jan; 69 (1): 95\u2013102.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tailoring early-phase clinical trial design to address multiple research objectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0050",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076022107",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "95",
                                    "@last": "102"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Wages",
                                        "ce:indexed-name": "Wages N.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Slingluff",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Slingluff C.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Bullock",
                                        "ce:indexed-name": "Bullock T.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Immunother"
                        },
                        "ce:source-text": "Wages NA, Slingluff CL, Jr., Bullock TN, et al. Tailoring early-phase clinical trial design to address multiple research objectives. Cancer Immunol Immunother. 2020 Jan; 69 (1): 95\u2013102."
                    },
                    {
                        "ref-fulltext": "Kumbhari A, Kim PS, Lee PP. Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells. J Theor Biol. 2020 Feb; ?486? (486): 110067.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0051",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85075070581",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "486"},
                                "pagerange": {"@first": "110067"}
                            },
                            "ref-text": "Feb",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kumbhari",
                                    "ce:indexed-name": "Kumbhari A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim P.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee P.P."
                                }
                            ]},
                            "ref-sourcetitle": "J Theor Biol"
                        },
                        "ce:source-text": "Kumbhari A, Kim PS, Lee PP. Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells. J Theor Biol. 2020 Feb; ?486? (486): 110067."
                    },
                    {
                        "ref-fulltext": "Gubin MM, Zhang X, Schuster H, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014 Nov 27; 515 (7528): 577\u2013581.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0052",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920921528",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "515",
                                    "@issue": "7528"
                                },
                                "pagerange": {
                                    "@first": "577",
                                    "@last": "581"
                                }
                            },
                            "ref-text": "Nov, 27",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gubin",
                                        "ce:indexed-name": "Gubin M.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuster",
                                        "ce:indexed-name": "Schuster H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Gubin MM, Zhang X, Schuster H, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014 Nov 27; 515 (7528): 577\u2013581."
                    },
                    {
                        "ref-fulltext": "Jackson NAC, Kester KE, Casimiro D, et al. The promise of mRNA vaccines: a biotech and industrial perspective. NPJ Vaccines. 2020; 5 (?1?): 11.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The promise of mRNA vaccines: a biotech and industrial perspective"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0053",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078936639",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {"@first": "11"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Jackson",
                                        "ce:indexed-name": "Jackson N.A.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Kester",
                                        "ce:indexed-name": "Kester K.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Casimiro",
                                        "ce:indexed-name": "Casimiro D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "NPJ Vaccines"
                        },
                        "ce:source-text": "Jackson NAC, Kester KE, Casimiro D, et al. The promise of mRNA vaccines: a biotech and industrial perspective. NPJ Vaccines. 2020; 5 (?1?): 11."
                    },
                    {
                        "ref-fulltext": "McNamara MA, Nair SK, Holl EKRNA. ?RNA-Based? Vaccines in Cancer Immunotherapy. J Immunol Res. 2015; ?2015?: 794528.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "?RNA-Based? Vaccines in Cancer Immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0054",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84948807547",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2015"},
                                "pagerange": {"@first": "794528"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "McNamara",
                                    "ce:indexed-name": "McNamara M.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Nair",
                                    "ce:indexed-name": "Nair S.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.K.R.N.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Holl",
                                    "ce:indexed-name": "Holl E.K.R.N.A."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunol Res"
                        },
                        "ce:source-text": "McNamara MA, Nair SK, Holl EKRNA. ?RNA-Based? Vaccines in Cancer Immunotherapy. J Immunol Res. 2015; ?2015?: 794528."
                    },
                    {
                        "ref-fulltext": "Gomez-Aguado I, Rodriguez-Castejon J, Vicente-Pascual M, et al. Nanomedicines to Deliver mRNA: state of the Art and Future Perspectives. Nanomaterials (Basel). 2020 Feb 20; 10 (?2?): 2.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Nanomedicines to Deliver mRNA: state of the Art and Future Perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0055",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079849634",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "2"
                                },
                                "pagerange": {"@first": "2"}
                            },
                            "ref-text": "Feb, 20",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Gomez-Aguado",
                                        "ce:indexed-name": "Gomez-Aguado I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez-Castejon",
                                        "ce:indexed-name": "Rodriguez-Castejon J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Vicente-Pascual",
                                        "ce:indexed-name": "Vicente-Pascual M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nanomaterials (Basel)"
                        },
                        "ce:source-text": "Gomez-Aguado I, Rodriguez-Castejon J, Vicente-Pascual M, et al. Nanomedicines to Deliver mRNA: state of the Art and Future Perspectives. Nanomaterials (Basel). 2020 Feb 20; 10 (?2?): 2."
                    },
                    {
                        "ref-fulltext": "Steinle H, Behring A, Schlensak C, et al. Concise Review: application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: progress and Challenges. Stem Cells. 2017 Jan; 35 (1): 68\u201379.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Concise Review: application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: progress and Challenges"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0056",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978794972",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "68",
                                    "@last": "79"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Steinle",
                                        "ce:indexed-name": "Steinle H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Behring",
                                        "ce:indexed-name": "Behring A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Schlensak",
                                        "ce:indexed-name": "Schlensak C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Stem Cells"
                        },
                        "ce:source-text": "Steinle H, Behring A, Schlensak C, et al. Concise Review: application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: progress and Challenges. Stem Cells. 2017 Jan; 35 (1): 68\u201379."
                    },
                    {
                        "ref-fulltext": "Kowalczyk A, Doener F, Zanzinger K, et al. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine. 2016 Jul 19; 34 (33): 3882\u20133893.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0057",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84977497384",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "34",
                                    "@issue": "33"
                                },
                                "pagerange": {
                                    "@first": "3882",
                                    "@last": "3893"
                                }
                            },
                            "ref-text": "Jul, 19",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kowalczyk",
                                        "ce:indexed-name": "Kowalczyk A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Doener",
                                        "ce:indexed-name": "Doener F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Zanzinger",
                                        "ce:indexed-name": "Zanzinger K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Kowalczyk A, Doener F, Zanzinger K, et al. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine. 2016 Jul 19; 34 (33): 3882\u20133893."
                    },
                    {
                        "ref-fulltext": "Schlake T, Thess A, Fotin-Mleczek M, et al. Developing mRNA-vaccine technologies. RNA Biol. 2012 Nov; 9 (11): 1319\u20131330.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Developing mRNA-vaccine technologies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0058",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84870886906",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1319",
                                    "@last": "1330"
                                }
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Schlake",
                                        "ce:indexed-name": "Schlake T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Thess",
                                        "ce:indexed-name": "Thess A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fotin-Mleczek",
                                        "ce:indexed-name": "Fotin-Mleczek M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "RNA Biol"
                        },
                        "ce:source-text": "Schlake T, Thess A, Fotin-Mleczek M, et al. Developing mRNA-vaccine technologies. RNA Biol. 2012 Nov; 9 (11): 1319\u20131330."
                    },
                    {
                        "ref-fulltext": "Kreiter S, Selmi A, Diken M, et al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Cancer Res. 2010 Nov 15; 70 (22): 9031\u20139040.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0059",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78549283854",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "70",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "9031",
                                    "@last": "9040"
                                }
                            },
                            "ref-text": "Nov, 15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kreiter",
                                        "ce:indexed-name": "Kreiter S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Selmi",
                                        "ce:indexed-name": "Selmi A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Diken",
                                        "ce:indexed-name": "Diken M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Kreiter S, Selmi A, Diken M, et al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Cancer Res. 2010 Nov 15; 70 (22): 9031\u20139040."
                    },
                    {
                        "ref-fulltext": "Sahin U, Oehm P, Derhovanessian E, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020 Sep;585(7823):107-112.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0060",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087487359",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Sep;585(7823):107-112",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Sahin",
                                        "ce:indexed-name": "Sahin U."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Oehm",
                                        "ce:indexed-name": "Oehm P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Derhovanessian",
                                        "ce:indexed-name": "Derhovanessian E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Sahin U, Oehm P, Derhovanessian E, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020 Sep;585(7823):107-112."
                    },
                    {
                        "ref-fulltext": "Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS-CoV-2 \u2014 preliminary Report. N Engl J Med. 2020 Nov 12; 383 (20): 1920\u20131931.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "An mRNA Vaccine against SARS-CoV-2 \u2014 preliminary Report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0061",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096120857",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "383",
                                    "@issue": "20"
                                },
                                "pagerange": {
                                    "@first": "1920",
                                    "@last": "1931"
                                }
                            },
                            "ref-text": "Nov, 12",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Jackson",
                                        "ce:indexed-name": "Jackson L.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson E.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Rouphael",
                                        "ce:indexed-name": "Rouphael N.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS-CoV-2 \u2014 preliminary Report. N Engl J Med. 2020 Nov 12; 383 (20): 1920\u20131931."
                    },
                    {
                        "ref-fulltext": "Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0062",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098117107",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Dec 31;383(27):2603-2615",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Polack",
                                        "ce:indexed-name": "Polack F.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Thomas",
                                        "ce:indexed-name": "Thomas S.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Kitchin",
                                        "ce:indexed-name": "Kitchin N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615."
                    },
                    {
                        "ref-fulltext": "Sahin U, Derhovanessian E, Miller M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017 Jul 13; 547 (7662): 222\u2013226.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0063",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85024396858",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "547",
                                    "@issue": "7662"
                                },
                                "pagerange": {
                                    "@first": "222",
                                    "@last": "226"
                                }
                            },
                            "ref-text": "Jul, 13",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Sahin",
                                        "ce:indexed-name": "Sahin U."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Derhovanessian",
                                        "ce:indexed-name": "Derhovanessian E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Miller",
                                        "ce:indexed-name": "Miller M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Sahin U, Derhovanessian E, Miller M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017 Jul 13; 547 (7662): 222\u2013226."
                    },
                    {
                        "ref-fulltext": "Nair S, Archer GE, Tedder TF. Isolation and generation of human dendritic cells. Curr Protoc Immunol. 2012 Nov; ?Chapter 7?: 7 32. Chapter 7:Unit.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Isolation and generation of human dendritic cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0064",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84875813276",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "?Chapter 7?"},
                                "pagerange": {"@first": "7 32"}
                            },
                            "ref-text": "Nov, Chapter 7:Unit",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Nair",
                                    "ce:indexed-name": "Nair S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Archer",
                                    "ce:indexed-name": "Archer G.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Tedder",
                                    "ce:indexed-name": "Tedder T.F."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Protoc Immunol"
                        },
                        "ce:source-text": "Nair S, Archer GE, Tedder TF. Isolation and generation of human dendritic cells. Curr Protoc Immunol. 2012 Nov; ?Chapter 7?: 7 32. Chapter 7:Unit."
                    },
                    {
                        "ref-fulltext": "Santos PM, Butterfield LH. Dendritic ?Cell\u2013Based? Cancer Vaccines. J Immunol. 2018 Jan 15; 200 (2): 443\u2013449.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Dendritic ?Cell\u2013Based? Cancer Vaccines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0065",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044666399",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "200",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "443",
                                    "@last": "449"
                                }
                            },
                            "ref-text": "Jan, 15",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Santos",
                                    "ce:indexed-name": "Santos P.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Butterfield",
                                    "ce:indexed-name": "Butterfield L.H."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunol"
                        },
                        "ce:source-text": "Santos PM, Butterfield LH. Dendritic ?Cell\u2013Based? Cancer Vaccines. J Immunol. 2018 Jan 15; 200 (2): 443\u2013449."
                    },
                    {
                        "ref-fulltext": "Tran E, Turcotte S, Gros A, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014 May 9; 344 (6184): 641\u2013645.",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0066",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84900301377",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "344",
                                    "@issue": "6184"
                                },
                                "pagerange": {
                                    "@first": "641",
                                    "@last": "645"
                                }
                            },
                            "ref-text": "May, 9",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Tran",
                                        "ce:indexed-name": "Tran E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Turcotte",
                                        "ce:indexed-name": "Turcotte S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gros",
                                        "ce:indexed-name": "Gros A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Tran E, Turcotte S, Gros A, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014 May 9; 344 (6184): 641\u2013645."
                    },
                    {
                        "ref-fulltext": "De Keersmaecker B, Claerhout S, Carrasco J, et al. TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma. J Immunother Cancer. 2020; 8 (?1?): 1. Feb.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0067",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85080839544",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "1"}
                            },
                            "ref-text": "Feb",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "De Keersmaecker",
                                        "ce:indexed-name": "De Keersmaecker B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Claerhout",
                                        "ce:indexed-name": "Claerhout S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Carrasco",
                                        "ce:indexed-name": "Carrasco J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "De Keersmaecker B, Claerhout S, Carrasco J, et al. TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma. J Immunother Cancer. 2020; 8 (?1?): 1. Feb."
                    },
                    {
                        "ref-fulltext": "Bassani-Sternberg M, Digklia A, Huber F, et al. A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients. Front Immunol. 2019; 10: 1832.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0068",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071415252",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "1832"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bassani-Sternberg",
                                        "ce:indexed-name": "Bassani-Sternberg M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Digklia",
                                        "ce:indexed-name": "Digklia A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Huber",
                                        "ce:indexed-name": "Huber F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Bassani-Sternberg M, Digklia A, Huber F, et al. A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients. Front Immunol. 2019; 10: 1832."
                    },
                    {
                        "ref-fulltext": "Carreno BM, Magrini V, Becker-Hapak M, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348 (6236): 803\u2013808.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0069",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928195112",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "348",
                                    "@issue": "6236"
                                },
                                "pagerange": {
                                    "@first": "803",
                                    "@last": "808"
                                }
                            },
                            "ref-text": "May, 15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Carreno",
                                        "ce:indexed-name": "Carreno B.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Magrini",
                                        "ce:indexed-name": "Magrini V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Becker-Hapak",
                                        "ce:indexed-name": "Becker-Hapak M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Carreno BM, Magrini V, Becker-Hapak M, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348 (6236): 803\u2013808."
                    },
                    {
                        "ref-fulltext": "Chen F, Zou Z, Du J, et al. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. J Clin Invest. 2019 May 1; 129 (5): 2056\u20132070.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0070",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062391409",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "129",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "2056",
                                    "@last": "2070"
                                }
                            },
                            "ref-text": "May, 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Zou",
                                        "ce:indexed-name": "Zou Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Du",
                                        "ce:indexed-name": "Du J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Chen F, Zou Z, Du J, et al. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. J Clin Invest. 2019 May 1; 129 (5): 2056\u20132070."
                    },
                    {
                        "ref-fulltext": "Sarivalasis A, Boudousquie C, Balint K, et al. A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma. J Transl Med. 2019 Nov 26; 17 (1): 391.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0071",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85075662998",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "391"}
                            },
                            "ref-text": "Nov, 26",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sarivalasis",
                                        "ce:indexed-name": "Sarivalasis A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Boudousquie",
                                        "ce:indexed-name": "Boudousquie C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Balint",
                                        "ce:indexed-name": "Balint K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Transl Med"
                        },
                        "ce:source-text": "Sarivalasis A, Boudousquie C, Balint K, et al. A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma. J Transl Med. 2019 Nov 26; 17 (1): 391."
                    },
                    {
                        "ref-fulltext": "Mitchell DA, Batich KA, Gunn MD, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 2015 Mar 19; 519 (7543): 366\u2013369.",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0072",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925045090",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "519",
                                    "@issue": "7543"
                                },
                                "pagerange": {
                                    "@first": "366",
                                    "@last": "369"
                                }
                            },
                            "ref-text": "Mar, 19",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Mitchell",
                                        "ce:indexed-name": "Mitchell D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Batich",
                                        "ce:indexed-name": "Batich K.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Gunn",
                                        "ce:indexed-name": "Gunn M.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Mitchell DA, Batich KA, Gunn MD, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 2015 Mar 19; 519 (7543): 366\u2013369."
                    },
                    {
                        "ref-fulltext": "Ashour D, Arampatzi P, Pavlovic V, et al. IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction. JCI Insight. 2020 May 21; 5 (?10?): 10.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0073",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085157701",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "10"
                                },
                                "pagerange": {"@first": "10"}
                            },
                            "ref-text": "May, 21",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Ashour",
                                        "ce:indexed-name": "Ashour D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Arampatzi",
                                        "ce:indexed-name": "Arampatzi P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Pavlovic",
                                        "ce:indexed-name": "Pavlovic V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JCI Insight"
                        },
                        "ce:source-text": "Ashour D, Arampatzi P, Pavlovic V, et al. IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction. JCI Insight. 2020 May 21; 5 (?10?): 10."
                    },
                    {
                        "ref-fulltext": "Lopes A, Vandermeulen G, ?PrÃ©at? PV. Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. J Exp Clin Cancer Res. 2019 Apr 5; 38 (1): 146.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cancer DNA vaccines: current preclinical and clinical developments and future perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0074",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064057237",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "146"}
                            },
                            "ref-text": "Apr, 5",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Lopes",
                                    "ce:indexed-name": "Lopes A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Vandermeulen",
                                    "ce:indexed-name": "Vandermeulen G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.V.",
                                    "@_fa": "true",
                                    "ce:surname": "PrÃ©at",
                                    "ce:indexed-name": "Preat P.V."
                                }
                            ]},
                            "ref-sourcetitle": "J Exp Clin Cancer Res"
                        },
                        "ce:source-text": "Lopes A, Vandermeulen G, ?PrÃ©at? PV. Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. J Exp Clin Cancer Res. 2019 Apr 5; 38 (1): 146."
                    },
                    {
                        "ref-fulltext": "Faurez F, Dory D, Le Moigne V, et al. Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine. 2010 May 21; 28 (23): 3888\u20133895.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0075",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77952424081",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "3888",
                                    "@last": "3895"
                                }
                            },
                            "ref-text": "May, 21",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Faurez",
                                        "ce:indexed-name": "Faurez F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dory",
                                        "ce:indexed-name": "Dory D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Le Moigne",
                                        "ce:indexed-name": "Le Moigne V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Faurez F, Dory D, Le Moigne V, et al. Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine. 2010 May 21; 28 (23): 3888\u20133895."
                    },
                    {
                        "ref-fulltext": "Diaz CM, Chiappori A, Aurisicchio L, et al. Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors. ?Journal of Translational Medicine?. 2013 Mar 8; 11 (?1?): 62.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0076",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84874978904",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "62"}
                            },
                            "ref-text": "Mar, 8",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz",
                                        "ce:indexed-name": "Diaz C.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiappori",
                                        "ce:indexed-name": "Chiappori A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aurisicchio",
                                        "ce:indexed-name": "Aurisicchio L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "?Journal of Translational Medicine?"
                        },
                        "ce:source-text": "Diaz CM, Chiappori A, Aurisicchio L, et al. Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors. ?Journal of Translational Medicine?. 2013 Mar 8; 11 (?1?): 62."
                    },
                    {
                        "ref-fulltext": "Tiriveedhi V, Fleming TP, Goedegebuure PS, et al. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells. Breast Cancer Res Treat. 2013 Feb; 138 (1): 109\u2013118.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0077",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84874664652",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "138",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "109",
                                    "@last": "118"
                                }
                            },
                            "ref-text": "Feb",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Tiriveedhi",
                                        "ce:indexed-name": "Tiriveedhi V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Fleming",
                                        "ce:indexed-name": "Fleming T.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Goedegebuure",
                                        "ce:indexed-name": "Goedegebuure P.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Breast Cancer Res Treat"
                        },
                        "ce:source-text": "Tiriveedhi V, Fleming TP, Goedegebuure PS, et al. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells. Breast Cancer Res Treat. 2013 Feb; 138 (1): 109\u2013118."
                    },
                    {
                        "ref-fulltext": "Tiriveedhi V, Tucker N, Herndon J, et al. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer. Clin Cancer Res. 2014 Dec 1; 20 (23): 5964\u20135975.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0078",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84918783221",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "5964",
                                    "@last": "5975"
                                }
                            },
                            "ref-text": "Dec, 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Tiriveedhi",
                                        "ce:indexed-name": "Tiriveedhi V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Tucker",
                                        "ce:indexed-name": "Tucker N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Herndon",
                                        "ce:indexed-name": "Herndon J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Tiriveedhi V, Tucker N, Herndon J, et al. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer. Clin Cancer Res. 2014 Dec 1; 20 (23): 5964\u20135975."
                    },
                    {
                        "ref-fulltext": "Trimble CL, Morrow MP, Kraynyak KA, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015 Nov 21; 386 (10008): 2078\u20132088.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0079",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84947869406",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "386",
                                    "@issue": "10008"
                                },
                                "pagerange": {
                                    "@first": "2078",
                                    "@last": "2088"
                                }
                            },
                            "ref-text": "Nov, 21",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Trimble",
                                        "ce:indexed-name": "Trimble C.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Morrow",
                                        "ce:indexed-name": "Morrow M.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kraynyak",
                                        "ce:indexed-name": "Kraynyak K.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Trimble CL, Morrow MP, Kraynyak KA, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015 Nov 21; 386 (10008): 2078\u20132088."
                    },
                    {
                        "ref-fulltext": "Duperret EK, Perales-Puchalt A, Stoltz R, et al. A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I ?CD8? ?+? T-cell Responses, Impacting Tumor Challenge. Cancer Immunol Res. 2019 Feb; 7 (2): 174\u2013182.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I ?CD8? ?+? T-cell Responses, Impacting Tumor Challenge"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0080",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060921550",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "174",
                                    "@last": "182"
                                }
                            },
                            "ref-text": "Feb",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Duperret",
                                        "ce:indexed-name": "Duperret E.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Perales-Puchalt",
                                        "ce:indexed-name": "Perales-Puchalt A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Stoltz",
                                        "ce:indexed-name": "Stoltz R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Duperret EK, Perales-Puchalt A, Stoltz R, et al. A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I ?CD8? ?+? T-cell Responses, Impacting Tumor Challenge. Cancer Immunol Res. 2019 Feb; 7 (2): 174\u2013182."
                    },
                    {
                        "ref-fulltext": "Li L, Zhang X, Wang X, et al. Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation. Genome Med. 2021.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0081",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85103559729",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Genome Med"
                        },
                        "ce:source-text": "Li L, Zhang X, Wang X, et al. Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation. Genome Med. 2021."
                    },
                    {
                        "ref-fulltext": "Arbelaez CA, Estrada J, Gessner MA, et al. A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses. NPJ Vaccines. 2020 Nov 12; 5 (1): 106.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0082",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85095876733",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "106"}
                            },
                            "ref-text": "Nov, 12",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Arbelaez",
                                        "ce:indexed-name": "Arbelaez C.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Estrada",
                                        "ce:indexed-name": "Estrada J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gessner",
                                        "ce:indexed-name": "Gessner M.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "NPJ Vaccines"
                        },
                        "ce:source-text": "Arbelaez CA, Estrada J, Gessner MA, et al. A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses. NPJ Vaccines. 2020 Nov 12; 5 (1): 106."
                    },
                    {
                        "ref-fulltext": "Lopez JS, Camidge R, Iafolla M, et al. Abstract CT301: a phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors. Cancer Res. 2020; 80 (16): CT301\u2013CT 301.",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Abstract CT301: a phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0083",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85099601375",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "80",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "CT301",
                                    "@last": "CT 301"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lopez",
                                        "ce:indexed-name": "Lopez J.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Iafolla",
                                        "ce:indexed-name": "Iafolla M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Lopez JS, Camidge R, Iafolla M, et al. Abstract CT301: a phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors. Cancer Res. 2020; 80 (16): CT301\u2013CT 301."
                    },
                    {
                        "ref-fulltext": "Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012 Mar 8; 366 (10): 883\u2013892.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0084",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84863393080",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "366",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "883",
                                    "@last": "892"
                                }
                            },
                            "ref-text": "Mar, 8",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gerlinger",
                                        "ce:indexed-name": "Gerlinger M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rowan",
                                        "ce:indexed-name": "Rowan A.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Horswell",
                                        "ce:indexed-name": "Horswell S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012 Mar 8; 366 (10): 883\u2013892."
                    },
                    {
                        "ref-fulltext": "De Miguel-luken MJ, Mansinho A, Boni V, et al. Immunotherapy-based combinations: current status and perspectives. ?Current Opinion in Oncology?. 2017 Sep; 29 (5): 382\u2013394.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Immunotherapy-based combinations: current status and perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0085",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021781263",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "382",
                                    "@last": "394"
                                }
                            },
                            "ref-text": "Sep",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "De Miguel-luken",
                                        "ce:indexed-name": "De Miguel-luken M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Mansinho",
                                        "ce:indexed-name": "Mansinho A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Boni",
                                        "ce:indexed-name": "Boni V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "?Current Opinion in Oncology?"
                        },
                        "ce:source-text": "De Miguel-luken MJ, Mansinho A, Boni V, et al. Immunotherapy-based combinations: current status and perspectives. ?Current Opinion in Oncology?. 2017 Sep; 29 (5): 382\u2013394."
                    },
                    {
                        "ref-fulltext": "Liu CJ, Schaettler M, Blaha DT, et al. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro Oncol. 2020 Sep 29; 22 (9): 1276\u20131288.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0086",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092332002",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1276",
                                    "@last": "1288"
                                }
                            },
                            "ref-text": "Sep, 29",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu C.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Schaettler",
                                        "ce:indexed-name": "Schaettler M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Blaha",
                                        "ce:indexed-name": "Blaha D.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Liu CJ, Schaettler M, Blaha DT, et al. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro Oncol. 2020 Sep 29; 22 (9): 1276\u20131288."
                    },
                    {
                        "ref-fulltext": "Narayanan JSS, Ray P, Hayashi T, et al. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Cancer Immunol Res. 2019 Oct; 7 (10): 1714\u20131726.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0087",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072848991",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1714",
                                    "@last": "1726"
                                }
                            },
                            "ref-text": "Oct",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Narayanan",
                                        "ce:indexed-name": "Narayanan J.S.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Ray",
                                        "ce:indexed-name": "Ray P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Hayashi",
                                        "ce:indexed-name": "Hayashi T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Narayanan JSS, Ray P, Hayashi T, et al. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Cancer Immunol Res. 2019 Oct; 7 (10): 1714\u20131726."
                    },
                    {
                        "ref-fulltext": "Zhao J, Chen Y, Ding ?Z-Y?, et al. Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment. Front Pharmacol. 2019; 10: 1184.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0088",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074352071",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "1184"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.-Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ding",
                                        "ce:indexed-name": "Ding Z.-Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Zhao J, Chen Y, Ding ?Z-Y?, et al. Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment. Front Pharmacol. 2019; 10: 1184."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "St. Louis",
            "@id": "60273994",
            "affilname": "Alvin J. Siteman Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273994",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "St. Louis",
            "@id": "60022756",
            "affilname": "Washington University School of Medicine in St. Louis",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85103547768",
        "dc:description": "Introduction: Derived from genetic alterations, cancer neoantigens are proteins with novel amino acid sequences that can be recognized by the immune system. Recent evidence demonstrates that cancer neoantigens represent important targets of cancer immunotherapy. The goal of cancer neoantigen vaccines is to induce neoantigen-specific immune responses and antitumor immunity, while minimizing the potential for autoimmune toxicity. Advances in sequencing technologies, neoantigen prediction ?algorithms,? and other technologies have dramatically improved the ability to identify and prioritize cancer neoantigens. These advances have generated considerable enthusiasm for ?the ?development of neoantigen vaccines. Several neoantigen vaccine platforms are currently being evaluated in early phase clinical trials including the synthetic long peptide (SLP), RNA, dendritic cell (DC), and DNA vaccine platforms. Areas covered: In this review, we describe, evaluate the mechanism(s) of action, compare the advantages and disadvantages, and summarize early clinical experience with each vaccine platform. We provide perspectives on the future directions of the neoantigen vaccine field. All data are derived from PubMed and ClinicalTrials search updated in October 2020. Expert opinion: Although the initial clinical experience is promising, significant challenges to the success of neoantigen vaccines include limitations in neoantigen identification and the need to successfully target the immunosuppressive tumor microenvironment.",
        "pubmed-id": "33641576",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85103547768",
        "dc:creator": {"author": [{
            "ce:given-name": "Suangson",
            "preferred-name": {
                "ce:given-name": "Suangson",
                "ce:initials": "S.",
                "ce:surname": "Supabphol",
                "ce:indexed-name": "Supabphol S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022756",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Supabphol",
            "@auid": "57217653382",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217653382",
            "ce:indexed-name": "Supabphol S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85103547768"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103547768&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85103547768&origin=inward"
            }
        ],
        "source-id": "21351",
        "citedby-count": "15",
        "prism:volume": "30",
        "subtype": "ar",
        "dc:title": "Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy",
        "openaccess": "2",
        "prism:issn": "17447658 13543784",
        "publishercopyright": "Â© 2021 Informa UK Limited, trading as Taylor & Francis Group.",
        "prism:issueIdentifier": "5",
        "subtypeDescription": "Article",
        "prism:publicationName": "Expert Opinion on Investigational Drugs",
        "prism:pageRange": "529-541",
        "prism:endingPage": "541",
        "openaccessFlag": null,
        "prism:doi": "10.1080/13543784.2021.1896702",
        "prism:startingPage": "529",
        "dc:identifier": "SCOPUS_ID:85103547768",
        "dc:publisher": "Taylor and Francis Ltd."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Animals",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antigens, Neoplasm",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cancer Vaccines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immunotherapy",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Precision Medicine",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tumor Microenvironment",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "cancer vaccine"
        },
        {
            "@_fa": "true",
            "$": "clinical trial"
        },
        {
            "@_fa": "true",
            "$": "delivery platforms"
        },
        {
            "@_fa": "true",
            "$": "Neoantigen"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Suangson",
            "preferred-name": {
                "ce:given-name": "Suangson",
                "ce:initials": "S.",
                "ce:surname": "Supabphol",
                "ce:indexed-name": "Supabphol S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022756",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Supabphol",
            "@auid": "57217653382",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217653382",
            "ce:indexed-name": "Supabphol S."
        },
        {
            "ce:given-name": "Lijin",
            "preferred-name": {
                "ce:given-name": "Lijin",
                "ce:initials": "L.",
                "ce:surname": "Li",
                "ce:indexed-name": "Li L."
            },
            "@seq": "2",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022756",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756"
            },
            "ce:surname": "Li",
            "@auid": "7501453101",
            "author-url": "https://api.elsevier.com/content/author/author_id/7501453101",
            "ce:indexed-name": "Li L."
        },
        {
            "ce:given-name": "S. Peter",
            "preferred-name": {
                "ce:given-name": "S. Peter",
                "ce:initials": "S.P.",
                "ce:surname": "Goedegebuure",
                "ce:indexed-name": "Goedegebuure S.P."
            },
            "@seq": "3",
            "ce:initials": "S.P.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022756",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756"
                },
                {
                    "@id": "60273994",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273994"
                }
            ],
            "ce:surname": "Goedegebuure",
            "@auid": "7003362460",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003362460",
            "ce:indexed-name": "Goedegebuure S.P."
        },
        {
            "ce:given-name": "William E.",
            "preferred-name": {
                "ce:given-name": "William E.",
                "ce:initials": "W.E.",
                "ce:surname": "Gillanders",
                "ce:indexed-name": "Gillanders W.E."
            },
            "@seq": "4",
            "ce:initials": "W.E.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022756",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022756"
                },
                {
                    "@id": "60273994",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60273994"
                }
            ],
            "ce:surname": "Gillanders",
            "@auid": "7003463023",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003463023",
            "ce:indexed-name": "Gillanders W.E."
        }
    ]}
}}